Role of SHIP1 in bone biology

Annals of the New York Academy of Sciences

Volumn 1280, Issue 1, 2013, Pages 11-14

  Iyer, Sonia ^a   Margulies, Bryan S ^a   Kerr, William G ^a,b,c  

^a Department of Microbiology and Immunology ^*  (United States)

^b State University of New York Upstate Medical University: College of Medicine   (United States)

^c SYRACUSE UNIVERSITY   (United States)

Author keywords

Bone; Inositol phospholipid; Osteoblast; Osteoclast; PI3K; SHIP1

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN; PHOSPHATIDYLINOSITIDE; PROTEIN KINASE B; PROTEIN TYROSINE PHOSPHATASE SHP; SMAD PROTEIN; SMAD4 PROTEIN; SRC HOMOLOGY 2 DOMAIN CONTAINING INOSITOL 5' PHOSPHATASE 1; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ARTICLE; BONE; BONE CELL; CELL DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; CELL MEMBRANE; CELL PROLIFERATION; DOWNSTREAM PROCESSING; HEMATOPOIETIC STEM CELL; HOMEOSTASIS; HUMAN; IMMUNOCOMPETENT CELL; IN VIVO STUDY; MESENCHYMAL STEM CELL; MUSCLE CELL; OSTEOBLAST; OSTEOCLAST; OSTEOPOROSIS; PHENOTYPE; PROTEIN EXPRESSION;

EID: 84875644540     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/nyas.12091     Document Type: Article

References (22)

1. Kerr, W.G. 2011. Inhibitor and activator: dual functions for SHIP in immunity and cancer. Ann. N.Y. Acad. Sci. 1217: 1-17.
2. Peng, Q. et al. 2010. TREM2- and DAP12-dependent activation of PI3K requires DAP10 and is inhibited by SHIP1. Sci. Signal 3: ra38.
3. Hadjidakis, D.J. & I. Androulakis. 2006. Bone remodeling. Ann. N.Y. Acad. Sci. 1092: 385-396.
4. Caetano-Lopes, J., H. Canhao & J.E. Fonseca. 2009. Osteoimmunology-the hidden immune regulation of bone. Autoimmun. Rev. 8: 250-255.
5. Kerr, W.G., M.Y. Park, M. Maubert & R.W. Engelman. 2011. SHIP deficiency causes Crohn's disease-like ileitis. Gut 60: 177-188.
6. Takeshita, S. et al. 2002. SHIP-deficient mice are severely osteoporotic due to increased numbers of hyper-resorptive osteoclasts. Nat. Med. 8: 943-949.
7. Zhou, P. et al. 2006. SHIP1 negatively regulates proliferation of osteoclast precursors via Akt-dependent alterations in D-type cyclins and p27. J. Immunol. 177: 8777-8784.
8. Desponts, C., J.M. Ninos & W.G. Kerr. 2006. s-SHIP associates with receptor complexes essential for pluripotent stem cell growth and survival. Stem Cells Dev. 15: 641-646.
9. Hazen, A.L. et al. 2009. SHIP is required for a functional hematopoietic stem cell niche. Blood 113: 2924-2933.
10. Mendez-Ferrer, S. et al. 2010. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466: 829-834.
11. Maeda, S., M. Hayashi, S. Komiya, et al. 2004. Endogenous TGF-beta signaling suppresses maturation of osteoblastic mesenchymal cells. EMBO J. 23: 552-563.
12. Alliston, T., L. Choy, P. Ducy, et al. 2001. TGF-beta-induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation. EMBO J. 20: 2254-2272.
13. Karsenty, G. et al. 1999. Cbfa1 as a regulator of osteoblast differentiation and function. Bone 25: 107-108.
14. Zhou, S. 2011. TGF-beta regulates beta-catenin signaling and osteoblast differentiation in human mesenchymal stem cells. J. Cell Biochem. 112: 1651-1660.
15. Krishnan, V., H.U. Bryant & O.A. Macdougald. 2006. Regulation of bone mass by Wnt signaling. J. Clin. Invest. 116: 1202-1209.
16. Liu, F., S. Kohlmeier & C.Y. Wang. 2008. Wnt signaling and skeletal development. Cell Signal 20: 999-1009.
17. Tsurukai, T., N. Udagawa, K. Matsuzaki, et al. 2000. Roles of macrophage-colony stimulating factor and osteoclast differentiation factor in osteoclastogenesis. J. Bone Miner. Metab. 18: 177-184.
18. Calvi, L.M. et al. 2003. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425: 841-846.
19. Williams, S.A. et al. 2011. USP1 deubiquitinates ID proteins to preserve a mesenchymal stem cell program in osteosarcoma. Cell 146: 918-930.
20. Perry, J.M. et al. 2011. Cooperation between both Wnt/{beta}-catenin and PTEN/PI3K/Akt signaling promotes primitive hematopoietic stem cell self-renewal and expansion. Genes Dev. 25: 1928-1942.
21. Peng, Y. et al. 2004. Inhibitor of DNA binding/differentiation helix-loop-helix proteins mediate bone morphogenetic protein-induced osteoblast differentiation of mesenchymal stem cells. J. Biol. Chem. 279: 32941-32949.
22. Pan, H. et al. 2010. SMAD4 is required for development of maximal endotoxin tolerance. J. Immunol. 184: 5502-5509.